IL17A and rheumatoid arthritis: First of all, it would be of interest to assess whether the association between IL-17A gene polymorphism and expression observed in healthy individuals (Espinoza et al. 2011) is also valid in RA patients, and furthermore to verify the association after subsequent 3 and 6 months of anti-TNF treatment.